Transplant International is a leading journal dedicated to the science and practice of organ transplantation. Its focus is on publishing high-impact research that advances the field of transplantation, encompassing clinical, experimental, and ethical aspects. It presents original articles, reviews, and editorials on a broad range of topics, including solid organ transplantation, hematopoietic stem cell transplantation, and tissue engineering. The journal covers areas like immunosuppression, graft rejection, infection management, and long-term outcomes.
Key areas of interest include the development of novel immunosuppressive strategies, the application of molecular diagnostics to personalize transplant care, and the exploration of regenerative medicine approaches to enhance graft survival. The journal serves as a forum for researchers, clinicians, and policymakers to exchange ideas and address the challenges of transplantation. The primary audience includes transplant surgeons, nephrologists, immunologists, and other health care professionals involved in transplant care. It is indexed in databases such as PubMed and Web of Science.
By promoting excellence in research and clinical practice, Transplant International aims to improve the lives of transplant recipients and advance the field of transplantation worldwide. The journal encourages submissions that contribute to the development of innovative therapies and strategies for improving transplant outcomes.